http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-2502003-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e61263b84630539d1fc5281e3bd9ac4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
filingDate 2001-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e13fff62a00d75626fa2f184c29782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b43efd04f1bcc33185cae602547794d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0920c398ccc6ae407bb78cae572bdbe1
publicationDate 2004-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SK-2502003-A3
titleOfInvention Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
abstract The present invention relates to a method for the preparation of hydrates of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno [2,3-b] [1,5] benzodiazepine (hereinafter referred to as Olanzapine). The present invention also relates to a process for conversion of these hydrates into a pure crystalline form of olanzapine referred to as form-I. The present invention also relates to a method of converting Olanzapine Form-2 to Form-1.
priorityDate 2000-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454235138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69898172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416061660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136242947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415964457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428157564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449779167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66650609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12206146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135446208
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135525650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448951039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424599094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19367859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448551011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69155226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452401917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID429551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69549798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421261471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452202257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53167

Total number of triples: 56.